Global Biotechnology Summit organizing committee with great honor extending you a warm invitation to attend the Global Biotechnology Summit which is slated to held in 16th August to 17th August 2023 in San Miguel de Tucuman, ARGENTINA. The Conference will offer a wide platform to share vital and recent innovations in the arena Global Biotechnology Summit. It also has a wonderful space for both scientific presentations like oral, poster and commercial exhibition. GBS have an exciting program that will allow the participants to reflect upon and celebrate the past accomplishments, renew friendships, extended networking opportunities, foster communication between speakers and delegates and jointly unveil current and future research directions. We hope that you will have a useful and fun filled time in San Miguel de Tucuman, ARGENTINA at this special GBS. We look forward to welcoming you all for what promises to be an outstanding event.
Magnus Group whole heartedly welcomes you to its “International conference on Orphan Drugs and Rare Diseases” (Orphan Drugs 2023) as Online Event slated during August 17-19, 2023. The congress deliberations will be on the theme “Orphan drugs: Ray of hope for rare disease”.
The Orphan Drug Act (ODA) of 1983 obligated manufacturers to increase the scale of orphan drugs in order to treat rare diseases and the orphan drug landscape has changed dramatically since then. Orphan medication approvals have increased in the last decade and there are over 500 candidates for orphan diseases in the pipeline. Orphan Drugs Conference provides a platform for scientists, professors, researchers, healthcare specialists, academicians, practitioners and students to discuss their latest research findings, ideas, advancements, and applications. The Rare Disease Conferences also gives a remarkable opportunity for stakeholders in the orphan drug business to meet and network with top-tier government, pharmaceutical, biotech, non-profit, orphan drug developers and research organizations. Orphan Drug Conferences 2023 putting an agenda that address the driving macroeconomic factors, policies and issue that will steer the development of orphan drugs globally including access, collaborations, policies etc.
The assurance cookie is found and is being filtered in Google Analytics.
These cookies are used to collect information about how you interact
with our website and allow us to remember you. We use this
information in order to improve and customize your browsing
experience, and for analytics and metrics about our visitors both on
this website and other media. To find out more about the cookies we
use, see our